Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Bengt Hoepken"'
Autor:
Xenofon Baraliakos, Martin Rudwaleit, Pedro M Machado, Bengt Hoepken, Lars Bauer, Rachel Tham, Thomas Kumke, Mindy Kim
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Background A consensus definition for active sacroiliitis by MRI, mentioned in the Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (axSpA), was published in 2009 and included a qualitat
Externí odkaz:
https://doaj.org/article/126007b01be948edb4249597ec2dda05
Autor:
Atul Deodhar, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Lianne Gensler, Walter Maksymowych, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective There is a paucity of data on long-term clinical responses in patients with non-radiographic axial spondyloarthritis (nr-axSpA) based on their baseline objective signs of inflammation such as MRI or C-reactive protein (CRP) levels. This stu
Externí odkaz:
https://doaj.org/article/255ce8dc541946c78286251d8e855a46
Autor:
Martin Rudwaleit, Pedro M. Machado, Vanessa Taieb, Natasha de Peyrecave, Bengt Hoepken, Lianne S. Gensler
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 15 (2023)
Background: Patients with active axial spondyloarthritis (axSpA) exhibit more absences and lower levels of productivity in the workplace and household than the general population, which can improve upon treatment. Objectives: The objective of this st
Externí odkaz:
https://doaj.org/article/6a013dbb17ac4e61b73a99928eecf072
Autor:
Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha dePeyrecave, Atul Deodhar
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 9, Pp 794-801 (2022)
Objective Tumor necrosis factor inhibitors (TNFi) are an effective treatment for non‐radiographic axial spondyloarthritis (nr‐axSpA). To be eligible, however, many authorities require patients with nr‐axSpA to show active sacroiliitis on magnet
Externí odkaz:
https://doaj.org/article/07fdd47c79c04d2ab7b1f38ef75b414b
Autor:
Walter P. Maksymowych, Thomas Kumke, Simone E. Auteri, Bengt Hoepken, Lars Bauer, Martin Rudwaleit
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-11 (2021)
Abstract Background Identification of predictive clinical factors of long-term treatment response may contribute to improved management of non-radiographic axSpA (nr-axSpA) patients. This analysis aims to identify whether any baseline characteristics
Externí odkaz:
https://doaj.org/article/e135e3addbda498a82cbb3a7a1b8314d
Autor:
Robert Landewé, Désirée van der Heijde, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Walter P Maksymowych, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/8438045dbb484717aea736704faa3669
Autor:
Robert Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip Van den Bosch, Karl Gaffney, Lars Bauer, Bengt Hoepken, Natasha de Peyrecave, Karen Thomas, Lianne S. Gensler
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 3, Pp 581-599 (2020)
Abstract Introduction Achievement of remission is a key treatment goal for patients with axial spondyloarthritis (axSpA). C-OPTIMISE assessed achievement of sustained clinical remission in patients with axSpA, including radiographic (r) and non-radio
Externí odkaz:
https://doaj.org/article/d24ddd10a84d4d3dac2c84f1bf9d36df
Autor:
Irene E. van der Horst-Bruinsma, Rianne E. van Bentum, Frank D. Verbraak, Atul Deodhar, Thomas Rath, Bengt Hoepken, Oscar Irvin-Sellers, Karen Thomas, Lars Bauer, Martin Rudwaleit
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Introduction: Acute anterior uveitis (AAU), affecting up to 40% of patients with axial spondyloarthritis (axSpA), risks permanent visual deficits if not adequately treated. We report 2-year results from C-VIEW, the first study to prospectively invest
Externí odkaz:
https://doaj.org/article/051a84f4af6042769a3a4200020e1831
Autor:
Martin Rudwaleit, James T Rosenbaum, Irene van der Horst-Bruinsma, Maria Misterska-Skora, Rianne van Bentum, Frank D Verbraak, Thomas Rath, Bengt Hoepken, Oscar Irvin-Sellers, Brenda VanLunen, Lars Bauer
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Background Acute anterior uveitis (AAU) is the most common extra-articular manifestation in patients with axial spondyloarthritis (axSpA). C-VIEW investigates the impact of the Fc-free TNF inhibitor certolizumab pegol (CZP) on AAU flares in patients
Externí odkaz:
https://doaj.org/article/6339948a645946ac82c8b7b88be8913f
Autor:
Philip C. Robinson, Walter P. Maksymowych, Lianne S. Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha de Peyrecave, Atul Deodhar
Publikováno v:
ACR Open Rheumatology. 4:794-801